hrs-9231
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Jun 5, 2024 (NCT07123376)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07275814 | Phase 3 | Nov 17, 2025 | Government of China |
| NCT07275723 | Phase 3 | Nov 14, 2025 | Government of China |
| NCT06731829 | Phase 2 | Dec 31, 2024 | Hengrui Therapeutics, Inc. |
| NCT06657560 | Phase 1 | Oct 14, 2024 | Government of China |
| NCT07123376 | Phase 1 | Jun 5, 2024 | Government of China |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 4 | 4 | 2 | 2024 |
| Hengrui Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1